Prof. Raj Chopra

Supervisory Investment Committee Member - Life Sciences

Professor Raj Chopra is Director of the Cancer Research UK Cancer Therapeutics Unit and Head of the Division of Cancer Therapeutics.  He is currently a member of the Cancer Research UK Drug Discovery Committee and of the Scientific Board of the California Institute of Regenerative Medicine (CIRM).  Raj received his M.D. at the University College and Middlesex School of Medicine, London and his Ph.D. from the University of London. Raj was previously part of the leadership team for the largest Oncology group in AstraZeneca, and established Translational Medicine for AstraZeneca in Boston, Massachusetts, US. He was also a leader within the Executive R&D Team and Corporate Vice President of Translational and Early Drug Development at Celgene Corporation.  In addition, he has been a Non-Executive Director for e-Therapeutics (Oxford, UK) and has been on the Board of Agios (Boston, Massachusetts, US).

Our People

Leave blank for all. Otherwise, the first selected term will be the default instead of "Any".